Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closed to Accrual

Canadian Cancer Trials Group IND.191 -- Phase II Study of AT9283 in Patients with Relapsed or Refractory Multiple Myeloma -- was closed to accrual on July 26, 2012.